Literature DB >> 15070086

Cell penetrating peptides in drug delivery.

Eric L Snyder1, Steven F Dowdy.   

Abstract

Protein transduction domains (PTDs) are small cationic peptides that can facilitate the uptake of large, biologically active molecules into mammalian cells. Recent reports have suggested that PTDs may be able to mediate the delivery of cargo to tissues throughout a living organism. Such technology could eliminate the size restrictions on usable drugs, enabling previously unavailable large molecules to modulate in vivo biology and alleviate disease. In this article, we review the evidence that PTDs can be used both to deliver active molecules to pathological tissue in vivo and to treat models of disease such as ischemia, inflammation, and cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15070086     DOI: 10.1023/B:PHAM.0000019289.61978.f5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  43 in total

1.  SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-IAP).

Authors:  Domagoj Vucic; Kurt Deshayes; Heidi Ackerly; Maria Teresa Pisabarro; Saloumeh Kadkhodayan; Wayne J Fairbrother; Vishva M Dixit
Journal:  J Biol Chem       Date:  2002-01-18       Impact factor: 5.157

2.  Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein.

Authors:  M Green; P M Loewenstein
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

3.  Pharmacokinetics and delivery of tat and tat-protein conjugates to tissues in vivo.

Authors:  H J Lee; W M Pardridge
Journal:  Bioconjug Chem       Date:  2001 Nov-Dec       Impact factor: 4.774

4.  The third helix of the Antennapedia homeodomain translocates through biological membranes.

Authors:  D Derossi; A H Joliot; G Chassaing; A Prochiantz
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

5.  Doxorubicin-peptide conjugates overcome multidrug resistance.

Authors:  M Mazel; P Clair; C Rousselle; P Vidal; J M Scherrmann; D Mathieu; J Temsamani
Journal:  Anticancer Drugs       Date:  2001-02       Impact factor: 2.248

6.  New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy.

Authors:  C Rousselle; P Clair; J M Lefauconnier; M Kaczorek; J M Scherrmann; J Temsamani
Journal:  Mol Pharmacol       Date:  2000-04       Impact factor: 4.436

7.  Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes.

Authors:  Vladimir P Torchilin; Tatyana S Levchenko; Ram Rammohan; Natalia Volodina; Brigitte Papahadjopoulos-Sternberg; Gerard G M D'Souza
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

8.  Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins.

Authors:  Antonio Fittipaldi; Aldo Ferrari; Monica Zoppé; Caterina Arcangeli; Vittorio Pellegrini; Fabio Beltram; Mauro Giacca
Journal:  J Biol Chem       Date:  2003-05-27       Impact factor: 5.157

9.  In Vivo Delivery of a Bcl-xL Fusion Protein Containing the TAT Protein Transduction Domain Protects against Ischemic Brain Injury and Neuronal Apoptosis.

Authors:  Guodong Cao; Wei Pei; Hailiang Ge; Qinhua Liang; Yumin Luo; Frank R Sharp; Aigang Lu; Ruiqiong Ran; Steven H Graham; Jun Chen
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

10.  Transducible peptide therapy for uveal melanoma and retinoblastoma.

Authors:  J William Harbour; Lori Worley; Duanduan Ma; Michael Cohen
Journal:  Arch Ophthalmol       Date:  2002-10
View more
  88 in total

1.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

2.  A novel human derived cell-penetrating peptide in drug delivery.

Authors:  Jian Zhao; Peng Gao; Wei Xiao; Li-Qiang Fan; Fu-Jun Wang; Su-Xia Li; Jian-Wen Liu
Journal:  Mol Biol Rep       Date:  2010-11-16       Impact factor: 2.316

3.  Real-time transmembrane translocation of penetratin driven by light-generated proton pumping.

Authors:  Jörgen Björklund; Henrik Biverståhl; Astrid Gräslund; Lena Mäler; Peter Brzezinski
Journal:  Biophys J       Date:  2006-06-16       Impact factor: 4.033

4.  Multilayered films fabricated from an oligoarginine-conjugated protein promote efficient surface-mediated protein transduction.

Authors:  Christopher M Jewell; Stephen M Fuchs; Ryan M Flessner; Ronald T Raines; David M Lynn
Journal:  Biomacromolecules       Date:  2007-02-02       Impact factor: 6.988

5.  Cellular uptake of fluorescent labelled biotin-streptavidin microspheres.

Authors:  M Bradley; L Alexander; R M Sanchez-Martin
Journal:  J Fluoresc       Date:  2008-03-11       Impact factor: 2.217

Review 6.  Cell penetrating elastin-like polypeptides for therapeutic peptide delivery.

Authors:  Gene L Bidwell; Drazen Raucher
Journal:  Adv Drug Deliv Rev       Date:  2010-05-15       Impact factor: 15.470

7.  Real-time analysis of uptake and bioactivatable cleavage of luciferin-transporter conjugates in transgenic reporter mice.

Authors:  Paul A Wender; Elena A Goun; Lisa R Jones; Thomas H Pillow; Jonathan B Rothbard; Rajesh Shinde; Christopher H Contag
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-11       Impact factor: 11.205

8.  Rational design of a biomimetic cell penetrating peptide library.

Authors:  Emmanouil D Karagiannis; Aleksandra M Urbanska; Gaurav Sahay; Jeisa M Pelet; Siddharth Jhunjhunwala; Robert Langer; Daniel G Anderson
Journal:  ACS Nano       Date:  2013-09-30       Impact factor: 15.881

9.  Neuroprotective effect of TAT PTD-Ngb fusion protein on primary cortical neurons against hypoxia-induced apoptosis.

Authors:  Guoyu Zhou; Peiyan Shan; Xueqiang Hu; Xueping Zheng; Shengnian Zhou
Journal:  Neurol Sci       Date:  2013-03-02       Impact factor: 3.307

10.  Enhanced cytotoxicity of TATp-bearing paclitaxel-loaded micelles in vitro and in vivo.

Authors:  Rupa R Sawant; Vladimir P Torchilin
Journal:  Int J Pharm       Date:  2009-03-27       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.